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ABSTRACT
Study queStion
Is protracted exposure to low doses of ionising 
radiation associated with an increased risk of solid 
cancer?
MethodS
In this cohort study, 308 297 workers in the nuclear 
industry from France, the United Kingdom, and the 
United States with detailed monitoring data for 
external exposure to ionising radiation were linked to 
death registries. Excess relative rate per Gy of radiation 
dose for mortality from cancer was estimated. 
Follow-up encompassed 8.2 million person years. Of 
66 632 known deaths by the end of follow-up, 17 957 
were due to solid cancers.
Study anSwer and liMitationS
Results suggest a linear increase in the rate of cancer 
with increasing radiation exposure. The average 
cumulative colon dose estimated among exposed 
workers was 20.9 mGy (median 4.1 mGy). The 
estimated rate of mortality from all cancers excluding 
leukaemia increased with cumulative dose by 48% per 
Gy (90% confidence interval 20% to 79%), lagged by 
10 years. Similar associations were seen for mortality 
from all solid cancers (47% (18% to 79%)), and within 
each country. The estimated association over the dose 
range of 0-100 mGy was similar in magnitude to that 
obtained over the entire dose range but less precise. 
Smoking and occupational asbestos exposure are 
potential confounders; however, exclusion of deaths 
from lung cancer and pleural cancer did not affect the 
estimated association. Despite substantial efforts to 
characterise the performance of the radiation 
dosimeters used, the possibility of measurement error 
remains. 
what thiS Study addS
The study provides a direct estimate of the association 
between protracted low dose exposure to ionising 
radiation and solid cancer mortality. Although high 
dose rate exposures are thought to be more dangerous 
than low dose rate exposures, the risk per unit of 
radiation dose for cancer among radiation workers was 
similar to estimates derived from studies of Japanese 
atomic bomb survivors. Quantifying the cancer risks 
associated with protracted radiation exposures can 
help strengthen the foundation for radiation protection 
standards. 
Funding, CoMpeting intereStS, data Sharing
Support from the US Centers for Disease Control and 
Prevention; Ministry of Health, Labour and Welfare of 
Japan; Institut de Radioprotection et de Sûreté 
Nucléaire; AREVA; Electricité de France; US National 
Institute for Occupational Safety and Health; US 
Department of Energy; and Public Health England. 
Data are maintained and kept at the International 
Agency for Research on Cancer.
Introduction
In 1943, a large scale programme to develop nuclear 
weapons, and later nuclear power, began in the United 
States.1 Soon afterwards, nuclear programmes also 
began in the United Kingdom and France. These pro-
grammes have employed hundreds of thousands of 
workers over the past 70 years. In the 1990s, an interna-
tional study of cancer risk among radiation workers in 
three countries was carried out using a common core 
protocol, and this study subsequently was expanded to 
include 15 countries.2 3 Cohorts of workers from France, 
the UK, and the USA provided the vast majority of the 
information available on early nuclear workers 
included in that study,3 and each of these cohorts has 
been updated recently.4-6
The updated cohorts of nuclear workers from France, 
the UK, and the USA have been pooled, and an epidemi-
ological analysis of cancer mortality conducted, as part 
of the International Nuclear Workers Study (INWORKS). 
These cohorts are among the largest, oldest, and most 
informative groups of nuclear workers in the world. 
They include men and women who have been moni-
tored for external exposure to radiation using personal 
dosimeters and have been followed up over decades to 
WhAT IS AlReAdy knoWn on ThIS TopIC
Ionising radiation is an established cause of cancer
The primary quantitative basis for radiation protection standards comes from 
studies of people exposed to acute, high doses of ionising radiation
WhAT ThIS STudy AddS
In a study of workers exposed to radiation at low dose rates typically encountered in 
nuclear industries in France, the United Kingdom, and the United States, the results 
suggest a linear increase in the relative rate of cancer with increasing exposure to 
radiation
Contrary to the belief that high dose rate exposures are substantially more 
dangerous than low dose rate exposures, the risk per unit of radiation dose for 
cancer among radiation workers was similar to estimates derived from studies of 
Japanese atomic bomb survivors
Cancer risks that are associated with protracted radiation exposures can help 
strengthen the foundation for radiation protection standards
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collect information on causes of death. Here, we report 
on analysis of all cancer mortality, and solid cancer 
mortality. Analyses of death due to lymphatic and hae-
matopoietic cancer (including leukaemia) have been 
reported previously,7 and analyses of deaths due to 
non-malignant disease and specific types of solid can-
cer will be reported subsequently.
We aimed to strengthen the scientific basis for the 
protection of adults from exposures to ionising radia-
tion with low doses and low dose rates. Despite strong 
evidence of low dose radiation effects on cancer after 
exposure in utero8-10 and supportive evidence of such 
associations following low dose exposures of diagnos-
tic radiation in childhood,11 12 epidemiological evidence 
of low dose radiation effects following exposure in 
adulthood has been more limited.13 
Methods
international consortium
INWORKS was established to provide a basis for deriv-
ing more precise quantitative estimates of the risk of 
chronic, low level, exposure to ionising radiation. To be 
included, workers must have been employed in the 
nuclear industry for at least one year and monitored for 
external radiation exposure through the use of personal 
dosimeters. From France, data were obtained from 
three major employers: Commissariat à l’Energie Atom-
ique, AREVA Nuclear Cycle, and Electricité de France.4 
From the UK, data were obtained through the National 
Registry for Radiation Workers, which includes infor-
mation provided by major employers of nuclear work-
ers including the Atomic Weapons Establishment, 
British Nuclear Fuels, UK Atomic Energy Authority, Brit-
ish Energy Generation, Magnox Electric, and the Minis-
try of Defence, among others.5  From the USA, data were 
obtained from the US Department of Energy’s Hanford 
site, Savannah River site, Oak Ridge National Labora-
tory, and Idaho National Laboratory, as well as from the 
Portsmouth Naval Shipyard.6 
In France, as required by the French Data Protection 
Authority, workers were given the opportunity to refuse 
participation; however, none did. In the USA, worker 
information was taken from existing records, with no 
direct contact with any participants; because there is 
minimal risk to participants, the National Institute for 
Occupational Safety and Health institutional review 
board waived requirements for informed consent. UK 
workers can refuse to participate in the National Regis-
try for Radiation Workers and associated studies; less 
than 1% refused.
dosimetric data
Personal monitoring data for occupational exposure to 
ionising radiation were available from company records 
for UK workers and government and company records 
for US and French workers, providing individual annual 
quantitative estimates of whole body dose due to exter-
nal exposure to penetrating radiation in the form of 
photons.14 Unless otherwise stated, any reference to 
dose in this paper implies absorbed dose to the colon 
expressed in grays (Gy). 
These analyses use estimated colon dose to facilitate 
comparison with other recent major analyses of associ-
ations between radiation dose and solid cancer mortal-
ity.3 15 Under most working conditions, absorbed doses 
from external exposures were due to photons of ener-
gies between 100 and 3000 kiloelectron volts (1.6e-14 J 
and 4.8e-13 J, respectively), with a radiation weighting 
factor of 1. Thus, estimates of absorbed dose in Gy could 
well be expressed in terms of equivalent dose in sievert 
(Sv) with similar numerical values. 
We used available records of estimated neutron 
doses, which were recorded in a unit of measure for 
equivalent dose (that is, rem or Sv), only to construct 
categories of neutron monitoring status: whether a 
worker had a positive recorded neutron dose, and if so, 
whether their recorded neutron dose ever exceeded 
10% of their total external radiation dose of record.14 16 
We did not add recorded estimates of doses from tritium 
intakes to recorded estimates of dose due to external 
exposures. 
Available measures of incorporated radionuclides 
were varied and included positive bioassay results, 
indication of confirmed uptake (for example, fraction of 
a body burden or annual limit on intake), or an assigned 
committed dose. For our purposes, we grouped these 
measures as an indication of a known or suspected 
internal contamination. French and US workers with a 
known or suspected uptake were identified, as were UK 
workers who were known to have been monitored for 
internal exposure.
Follow-up and ascertainment of causes of death
Vital status was ascertained through 2004, 2001, and 
2005 for the French, UK, and US cohorts, respectively, 
through linkage with national and regional death regis-
tries, employer records, and Social Security Administra-
tion records. Information on underlying cause of death 
was abstracted from death certificates and coded 
according to ICD-9 (international classification of dis-
eases, 9th revision) in effect at the time of death. All 
cancer mortality (ICD-9 codes 140-208) was examined 
because radiation induced cancers could occur at most, 
if not all, sites following whole body exposure to ionis-
ing radiation, and because death certificate data could 
be more accurate for identifying all cancers as a group 
than for identifying specific types of cancer. 
We examined all cancer excluding leukaemia (ICD-9 
codes 140-203) and solid cancer (codes 140-199) because 
these groups are typically used in studies that underlie 
radiation protection recommendations. Solid cancer 
excluding lung cancer (codes 140-199 except 162) was 
examined because lung cancer is strongly related to cig-
arette smoking. The exclusion of lung cancer offers an 
indirect method to address concerns that smoking 
might be associated with occupational radiation expo-
sure among nuclear industry workers, leading to bias in 
estimates of radiation-cancer associations.17 18 
We also examined the association between radiation 
dose and solid cancer excluding three main groups. 
Firstly, a large of group of smoking related cancers were 
excluded: cancers of the oral cavity and pharynx, 
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oesophagus, stomach, colon, rectum, liver, gallbladder, 
pancreas, nasal cavity, larynx, lung, cervix, ovary, 
 bladder, kidney, and ureter (ICD-9 codes 140-199 except 
140-151, 153-157, 160-162, 180, 183, and 188-189).19  The 
second group to be excluded was cancers of the lung, 
liver, and bone (codes 140-199 except 155, 162, and 170), 
which are three sites that receive substantial doses from 
incorporated plutonium.20 The third exclusion group 
was cancers of the lung and pleura (codes 140-199 
except 162 and 163), to address concerns regarding 
potential bias due to occupational asbestos exposure.
A person entered the study on the date of first dosim-
etric monitoring, or one year after the date of first 
employment, whichever was later. The national death 
registry in France provides individual information on 
causes of death only from 1968 onwards; therefore 
French workers entered follow-up on 1 January 1968 or 
later. A person exited the study on the earliest date of 
the following: date of death, date lost to follow-up, or 
end of follow-up.
Statistical methods
The statistical methods used were similar to those in 
previous international studies of nuclear workers.2 3 
The estimated colon dose due to external exposure to 
penetrating photons was the exposure of primary inter-
est. We quantified radiation dose-mortality associa-
tions using a Poisson regression model (relative 
rate=1+βZ, where Z is the cumulative dose in Gy and β is 
excess relative rate (the relative rate minus 1) per Gy).21 
Estimates of excess relative rate per Gy were adjusted, 
through stratification, for the effects of:
•	 Country
•	 Attained age (in five year intervals)
•	 Sex
•	 Year of birth (in 10 year intervals)
•	 Socioeconomic status:
•	 French, US, and UK workers employed by the 
Atomic Energy Authority and Atomic Weapons 
Establishment classified into five categories, 
based on job title: professional and technical 
workers, administrative staff, skilled workers, 
unskilled workers, and uncertain
•	 Other UK workers classified into two broader cate-
gories of non-industrial and industrial employees
•	 Duration of employment or radiation work (in 10 year 
intervals)
•	 Neutron monitoring status.14 16 
To allow for a minimal induction and latency period 
between exposure and death,22 cumulative doses were 
lagged by 10 years, facilitating comparison with other 
studies of solid cancer among nuclear workers.2 3 5  We 
undertook sensitivity analyses in which cumulative 
doses were lagged five years or 15 years, cumulative 
doses were restricted to the lower dose range, and 
women and workers flagged for internal contamina-
tion or monitoring were excluded. Results obtained 
under alternative lags were compared with respect to 
 goodness of model fit.23 
To evaluate the influence of a single country on over-
all results, analyses excluded one country at a time; 
and, a model with a product term between country and 
dose was fitted, allowing heterogeneity to be assessed 
based on the likelihood ratio test. To assess departures 
from linearity in the effect of cumulative dose, we fitted 
a model that included a higher order polynomial func-
tion of cumulative dose and evaluated the improvement 
in model goodness of fit. We examined the dose-re-
sponse association visually by fitting a regression 
model with indicator variables for categories of cumu-
lative dose and plotting the resultant relative rate esti-
mates against category specific, mean dose values. 
We examined results after further stratifying the data 
according to whether a worker was flagged for internal 
contamination or monitoring, and after adjusting for 
mortality differences between the major employers in 
each country. We estimated the excess number of 
deaths associated with radiation exposure by calculat-
ing the difference between the fitted number of deaths 
within a stratum defined by levels of the stratification 
variables and the background number of deaths 
(obtained by multiplying the stratum specific rate of 
mortality at baseline by the person time in that stra-
tum). 
The objective of radiation epidemiological studies is 
generally to evaluate whether there is an increased can-
cer risk following radiation exposure; therefore, one 
sided P values and corresponding 90% confidence 
intervals are often reported.2-5 24-26 Following this logic, 
we report 90% likelihood based confidence intervals for 
estimates of the excess relative rate per Gy. This also 
facilitates comparison of the precision of our estimated 
associations with findings reported in other important 
epidemiological studies of radiation exposed popula-
tions.2-5 24-26 All models were fit using the EPICURE soft-
ware package.
patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
the design and implementation of the study. There are 
no plans to involve patients in the dissemination of 
results.
Results
The study population included 308 297 workers (table 1). 
Of 66 632 (22%) known deaths at the end of follow-up, 
19 748 were identified to be due to cancer (n=684, leu-
kaemia; n=5802, lung cancer). The follow-up of this 
cohort encompasses 8.2 million person years, with 
median follow-up of 26 years per worker, and median 
length of employment of 12 years. The median attained 
age at the end of follow-up was 58 years. Most workers 
were men (87%, n=268 262), and 97% of the collective 
colon dose was accrued by men. Among the 257 166 
workers who had a positive recorded dose, the distribu-
tion of cumulative colon dose estimates was skewed 
(median 4.1 mGy, mean 20.9 mGy, 90th percentile 53.4 
mGy, maximum 1331.7 mGy). The total collective colon 
dose was 5370.3 person Gy.
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For all cancers, the excess relative rate was 0.51 per 
Gy (90% confidence interval 0.23 to 0.82); table 2). The 
excess relative rate was 0.48 per Gy (0.20 to 0.79) for all 
cancers other than leukaemia, and 0.47 per Gy (0.18 to 
0.79) for solid cancers. To indirectly assess confounding 
by smoking, we estimated the association between radi-
ation dose and solid cancers other than lung cancer 
(excess relative rate 0.46 per Gy (0.11 to 0.85)), and 
observed that the point estimate was similar that 
obtained for all solid cancers. To assess potential bias 
due to asbestos exposure, we estimated the association 
between radiation dose and solid cancers other than 
lung and pleural cancer (0.43 per Gy (0.08 to 0.82)), 
again similar in magnitude to the point estimate 
obtained for all solid cancers. 
Excluded cancers from the category of solid cancer 
(of the oral cavity and pharynx, oesophagus, stomach, 
colon, rectum, liver, gallbladder, pancreas, nasal cavity, 
larynx, lung, cervix, ovary, bladder, kidney, and ureter) 
yielded an estimated excess relative rate of 0.37 per Gy 
(90% confidence interval −0.14 to 0.95). The exclusion 
of this larger group of smoking related cancers, which 
constituted 70% of solid cancer deaths, thus resulted in 
a reduced magnitude and precision of the estimated 
excess relative rate per Gy. 
Sensitivity analyses were conducted under five and 15 
year lag assumptions (web table A1). Associations were 
slightly smaller in magnitude under a five year lag, and 
model goodness of fit was poorer than that obtained 
under our a priori 10 year lag assumption. Associations 
were slightly larger in magnitude under a 15 year lag 
with similar goodness of model fit than that obtained 
under a 10 year lag assumption.
A model describing a linear increase in the excess rel-
ative rate with dose appeared to provide a reasonable 
description of the data for all cancer other than leukae-
mia on visual examination (fig). Based on our fitted 
model, we estimated that about 209 of the 19 064 
observed deaths due to cancer other than leukaemia 
were excess deaths associated with external radiation 
exposure (web table A2). To formally assess departure 
from linearity, we fitted a model that also included a 
parameter for the square of cumulative dose; this inclu-
sion led to little improvement in the model goodness of 
fit (likelihood ratio test=0.58, df=1, P=0.44). To assess 
the trend over the lower cumulative dose range, we esti-
mated associations over restricted ranges of 0-200 mGy 
cumulative dose (excess relative rate 1.04 per Gy; 90% 
confidence interval 0.55 to 1.56), 0-150 mGy cumulative 
dose (0.69 per Gy; 0.10 to 1.30), and 0-100 mGy cumula-
tive dose (0.81 per Gy; 0.01 to 1.64; web fig S1).
To evaluate the effect of data from each country on 
the summary estimate for the pooled data, we excluded 
countries from the INWORKS cohort one at a time. Esti-
mates for the association between cumulative dose 
under a 10 year lag and all cancer mortality other than 
leukaemia was 0.48 per Gy (90% confidence interval 
0.19 to 0.80) after we excluded France, 0.39 per Gy 
(−0.03 to 0.85) after we excluded the UK, and 0.56 per Gy 
(0.19 to 0.97) after we excluded the USA from INWORKS. 
We saw no evidence of heterogeneity in the estimated 
associations by country based on a statistical test (like-
lihood ratio test=0.24, df=2, P=0.89) and visual exam-
ination of country specific estimates of association 
further supports such a conclusion (web fig S2). 
To assess potential bias due to differences (other than 
external radiation doses) between the major employers 
in each country, we fitted a model that adjusted for each 
of the main facilities included in INWORKS. We saw 
table 1 | Characteristics of cohorts included in the inworKS consortium (nuclear workers 
in France, uK, and uSa, 1944-2005)
France uK uS inworKS
Calendar years of follow-up 1968-2004 1946-2001 1944-2005 1944-2005
Workers (no) 59 003 147 866 101 428 308 297
Person years (millions) 1.5 3.4 3.3 8.2
Causes of death (no) 
 All causes 6310 25 307 35 015 66 632
 All cancer 2552 7558 9638 19 748
 All cancer other than leukaemia 2473 7350 9241 19 064
 Solid cancer 2356 6994 8607 17 957
 Solid cancer other than lung cancer 1761 4750 5644 12 155
Exposed workers (no)* 42 206 130 373 84 587 257 166
Collective dose (person Gy) 742.0 2936.1 1692.2 5370.3
Average individual cumulative dose 
(mGy)†
17.6 22.5 20.0 20.9
*Workers with cumulative dose greater than zero.
†Average estimated cumulative dose to the colon, among exposed workers.
table 2 | estimates of excess relative rate per gy for death 
due to specific cancer categories in inworKS*
Causes of death no of deaths
excess relative rate 
per gy (90% Ci)
All cancer 19 748 0.51 (0.23 to 0.82)
All cancer other than 
leukaemia
19 064 0.48 (0.20 to 0.79)
Solid cancer 17 957 0.47 (0.18 to 0.79)
Solid cancer other than 
lung cancer
12 155 0.46 (0.11 to 0.85)


























0 100 200 300 400 500 600 700
relative rate of mortality due to all cancer other than 
leukaemia by categories of cumulative colon dose, lagged 
10 years in inworKS. Vertical lines=90% confidence 
intervals; dashed line=fitted linear model for the change in 
the excess relative rate of mortality due to all cancer other 
than leukaemia with dose; numbers above vertical 
lines=number of deaths due to cancer other than 
leukaemia in that dose category. the number of cancers in 
the lowest dose category (n=10 433) has not been 
annotated on this figure for reasons of legibility
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 little change in the magnitude of the estimated associa-
tion on further adjustment for facility (excess relative 
rate of cancer other than leukaemia 0.43 per Gy; 90% 
confidence interval 0.13 to 0.75). We examined results 
after further stratifying the data according to whether a 
worker was identified based on a known or suspected 
uptake or monitoring for any radionuclide (excess rela-
tive rate of cancer other than leukaemia 0.46 per Gy; 
0.17 to 0.78); similarly, the estimated association was 
0.45 per Gy (0.16 to 0.78) on stratification according to 
whether a worker was identified based on a known or 
suspected uptake or monitoring for any radionuclide 
other than tritium. We estimated the association 
between radiation dose and solid cancers other than 
lung, liver, and bone cancer (excess relative rate 0.51 per 
Gy; 0.15 to 0.91), and observed that the point estimate 
was similar to that obtained for all solid cancers.
Because most deaths from cancer occurred among 
men, and 97% of the collective dose was accrued by 
men, we examined results in analyses restricted to men. 
The estimated excess relative rate for all cancer other 
than leukaemia was slightly larger after the exclusion of 
women (0.51 per Gy; 90% confidence interval 0.22 to 
0.82). Eighty seven per cent (n=268 523) of the workers 
in the INWORKS cohort had no reported dose from neu-
tron exposure. Because our primary interest was in the 
effect of protracted external exposure to penetrating 
radiation in the form of photons, we examined results 
in analyses restricted to workers with no reported neu-
tron dose (0.55 per Gy; 0.17 to 0.95). Similarly, because 
83% (n=256 772) of workers were never flagged for incor-
porated radionuclides or internal monitoring, we exam-
ined results in analyses restricted to these workers (0.72 
per Gy; 0.29 to 1.19).
discussion
principal findings
This study provides evidence of a linear increase in the 
excess relative rate of cancer mortality with increasing 
exposure to ionising radiation at the low dose rates typ-
ically encountered in the nuclear industries in France, 
the UK, and the USA. Restricting analyses to informa-
tion regarding doses below 200, 150, and 100 mGy 
showed that the estimated excess relative rate per Gy for 
all cancers other than leukaemia were not driven by the 
highest dose categories. Analyses restricted to these 
lower doses also address the radiation protection com-
munity’s interest in epidemiological evidence of a radi-
ation dose-cancer association in these low dose ranges. 
INWORKS thus provides supportive evidence for a pos-
itive association between radiation dose and all cancer 
other than leukaemia, even if less precise when analy-
ses are restricted to data for the 0-100 mGy dose range.
Comparison with other studies
The primary basis for the radiation risk estimates used 
to establish contemporary radiation protection stan-
dards comes from analyses of cancer in the Life Span 
Study of the Japanese atomic bomb survivors. Histori-
cally, it has been assumed that radiation-solid cancer 
associations diminish with falling dose rate. For example, 
the International Commission on Radiological Protec-
tion (2007) recommended that regulators divide the 
radiation risk coefficients obtained from the study of 
Japanese atomic bomb survivors in half when estimat-
ing risks for cancers other than leukaemia in settings 
with exposures of low dose and low dose rate radia-
tion.27  This was recommended because the high dose 
rate exposures from the atomic bombings were assumed 
to be more dangerous than the low dose rate exposures 
typically encountered by workers and members of the 
public.27  Questions about the effects of such low dose 
exposure have, in part, motivated studies of nuclear 
workers since the 1970s.28-33
Our estimated association between radiation and 
solid cancer (excess relative rate 0.47 per Gy; 90% con-
fidence interval 0.18 to 0.79) is larger than but statisti-
cally compatible with the estimate from a mortality 
analysis of male survivors of the Japanese atomic bomb 
exposed at ages 20-60 years (excess relative rate 0.32 
per Sv; 95% confidence interval 0.01 to 0.50).3 Statistical 
compatibility of risk estimates between studies may 
suggest some degree of coherence in the evidence 
derived from these large studies. However, in observa-
tional cohort studies, such as INWORKS and the Life 
Span Study of Japanese atomic bomb survivors,15 24 25 
large sample sizes and statistical precision are no pro-
tection against bias. We have attempted to deal with 
some concerns regarding bias through decisions in 
study design. To this end, INWORKS was not intended 
to assemble the largest number of nuclear workers pos-
sible, but rather to assemble those cohorts that were 
most informative with regard to quality and complete-
ness of exposure and follow-up data.
The parent study of the INWORKS collaboration 
included 407 391 workers from 15 countries.3 Although 
INWORKS included fewer nuclear workers than the 
earlier study, dose-response analyses in INWORKS 
encompassed substantially more cancer deaths than 
the parent study (17 957 v 4770 solid cancers), reflecting 
the extended follow-up of the INWORKS cohorts. 
INWORKS did not include data from Canada, a cohort 
for which the excess relative rate per Gy estimate was 
considerably larger than that observed in most other 
countries in the parent study, and for which concerns 
have been raised regarding data quality and complete-
ness.3 34 35 In our analysis, no single country’s data 
exerted a large impact on the magnitude of the sum-
mary risk estimate. Rather, a statistical test of heteroge-
neity by country rejected the conclusion of significant 
variation in the radiation-cancer association between 
the three countries.
The summary risk estimates in the current analysis 
are more precise and are larger in magnitude than those 
obtained from previous country specific analyses.4-6  For 
example, a previous analysis of data from France 
reported an estimated excess relative rate for solid can-
cers of 0.34 per Gy (90% confidence interval −0.56 to 
1.38).4 Data from the UK National Registry for Radiation 
Workers had an estimated excess relative rate for death 
due to cancers other than leukaemia of 0.28 per Gy (0.02 
to 0.56).5 Finally, data from the US showed an estimated 
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excess relative rate for cancers other than leukaemia of 
0.14 per Gy (−0.17 to 0.48).6 
Our estimated radiation risk coefficients could be 
somewhat larger than those in previous analyses of the 
constituent cohorts because we adjusted the recorded 
dose to account for bias in historical dosimeter 
response and attenuation, taking the estimated colon 
dose as the quantity of interest.14  Analysis of the 
INWORKS data using recorded photon dose as the dose 
metric, rather than adjusted estimates of colon dose, 
yielded somewhat lower estimates of association, 
although use of adjusted colon dose estimates resulted 
in no significant improvement in model goodness of fit 
(web table A3). This finding accords with the general 
principle that it is possible to use assumptions about 
patterns of exposure misclassification (for example, 
different exposure periods or conditions) to reduce 
bias, but it is much more difficult to recover the preci-
sion that would be obtained if one knew each person’s 
true exposure.36
Strengths and limitations of study
Our adjusted dose estimates drew on the substantial 
work done to characterise the performance of the vari-
ous radiation dosimeters used in France, the UK, and 
the USA over the study period and account for differ-
ences between countries and over time in dosimeter 
performance.37 38 Use of colon dose estimates facilitated 
comparison of our radiation risk estimates with those 
reported in mortality analyses of Japanese atomic bomb 
survivors that also related to estimated colon dose.39 
However, exposure measurement errors related to per-
sonal dosimeters, monitoring practices, and historical 
records, particularly in the early years of operation, 
remain a study limitation.37 38 Radiation exposures 
might also have occurred outside of employment at 
facilities for which we have dosimetry records, and 
some workers could have had occupational radiation 
exposures that were not identified in the records avail-
able for this study.
In view of our focus on mortality due to cancer, a rea-
sonable concern is potential confounding by cigarette 
smoking, which was unmeasured in our study.40  Con-
trary to the pattern that would be expected if there was 
confounding by smoking, the magnitude of the esti-
mated excess relative rate per Gy under a 10 year lag 
was essentially unchanged after excluding lung cancer. 
A separate paper on non-cancer disease further sup-
ports the conclusion of no significant confounding by 
smoking as evidenced by the lack of association 
between radiation dose and chronic obstructive pulmo-
nary disease, an outcome strongly associated with 
smoking.40  Although there has been interest in the joint 
effects of radiation and smoking on cancer risk,41 this 
could not be evaluated in our study. 
Similarly, we could not directly adjust for the effects 
of exposure to other known occupational lung carcino-
gens, such as asbestos. However, the magnitude of the 
estimated association between radiation dose and solid 
cancer mortality remained unchanged after the exclu-
sion of lung cancer (and further exclusion of pleural 
cancer). Therefore, occupational lung carcinogens may 
not be an important confounder in the overall analysis 
of the association between radiation and solid cancer. 
In INWORKS, adjustment for socioeconomic status 
reduced the magnitude of dose-response estimates, 
suggesting positive confounding by socioeconomic sta-
tus. This variable, which is primarily based on job title, 
is likely to be a poor proxy for factors that relate social 
class to mortality differences, and suggests the possibil-
ity of residual confounding of radiation-cancer associa-
tions by socioeconomic status. We adjusted for duration 
of work owing to evidence of a modest deficit in relative 
mortality among workers who had at least 10 years of 
radiation work, and a larger deficit in relative mortality 
among workers who had at least 30 years of radiation 
work.5  Stratification by duration of radiation work 
slightly increased estimates of association, suggesting 
negative confounding due to preferential retention of 
workers in better health (sometimes termed healthy 
worker survivor bias).42 We assessed the sensitivity to 
adjustment for these variables by fitting a simpler 
model that adjusted only for country, age, sex, and birth 
cohort. The estimated association between dose and 
cancer mortality other than leukaemia was similar in 
magnitude and precision to that obtained from the fully 
adjusted model, suggesting that the net effect of adjust-
ment for these variables was small (web table A4).
In the international collaborative study of cancer risk 
among radiation workers in the nuclear industry,3  peo-
ple with potential exposure to neutrons, which was dif-
ficult to reliably quantify using the historical personnel 
dosimeters, were excluded from analyses to focus on 
workers with well-measured photon doses.43  A concern 
raised regarding this exclusion was that it excluded a 
large number of workers with high cumulative external 
photon doses.44 
In the current analysis, we included workers with 
potential exposure to neutrons and adjusted where pos-
sible for neutron monitoring status. In sensitivity anal-
yses, we excluded the 13% of the cohort that ever had a 
recorded neutron dose. The resulting estimated associ-
ation between colon dose and mortality due to cancer 
other than leukaemia (excess relative rate 0.55 per Gy; 
90% confidence interval 0.17 to 0.95) was similar to that 
obtained for the whole cohort after adjustment for neu-
tron monitoring status (0.48 per Gy; 0.20 to 0.79). How-
ever, owing to the limitations of historical neutron 
dosimetry information, an analysis restricted to work-
ers with no recorded neutron dose is likely to have 
included workers who had unrecorded neutron expo-
sures, particularly among those employed in the early 
years of operations.45 
The estimated association among workers with a pos-
itive recorded neutron dose (excess relative rate 0.36 per 
Gy; 90% confidence interval −0.08 to 0.88) and those 
with a recorded neutron dose exceeding 10% of total 
dose (0.62 per Gy; −0.50 to 2.09) were also similar in 
magnitude to, but less precise than, the whole cohort 
estimate after adjustment for neutron monitoring sta-
tus. Therefore, the summary adjusted estimate does not 
appear to have obscured any meaningful heterogeneity 
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in the excess relative rate per Gy by neutron monitoring 
status (web table A5). 
Employees who had recorded neutron doses—which 
reflects work in radiologically controlled areas where 
neutron dosimeters were issued—tended to have lower 
baseline rates of cancer mortality than those who did 
not. Reduced mortality rates among workers in radio-
logically controlled areas has been attributed to factors 
such as restrictions on smoking in such areas, and addi-
tional medical screening for work in areas where addi-
tional hazards might occur.46  47  Adjustment for neutron 
monitoring status accounts for such differences in base-
line rates between groups, yielding a summary adjusted 
estimate comparable to the stratum specific estimates 
of excess relative rate per Gy. However, an unadjusted 
estimate produced a smaller value (0.20 per Gy; 90% 
confidence interval −0.03 to 0.46; web table A5). Adjust-
ment for neutron monitoring status, however, might be 
inadequate to fully control for differences in baseline 
rates between these groups, owing to limitations of his-
torical neutron dosimetry information. Furthermore, 
bias could persist in adjusted analyses if health related 
selection out of employment affects a worker’s future 
monitoring status and exposure history, and is itself 
affected by previous radiation exposure.42
INWORKS included workers with potential for com-
mitted doses from incorporated radionuclides. As a sen-
sitivity analysis, we excluded the 17% (n=51 525) of the 
cohort who had been identified on the basis of internal 
contamination or monitoring. This exclusion had a 
much larger effect for the UK cohort than for those in 
the USA or France. The UK had identified anyone moni-
tored for internal exposure, whereas the US and France 
identified anyone with a confirmed uptake. 
In the present study, after the exclusion of workers 
flagged for internal contamination or monitoring, the 
estimated association between colon dose and mortal-
ity due to cancer other than leukaemia was larger in 
magnitude than the estimate for the whole cohort. This 
difference was consistent with a previous observation 
that among UK nuclear workers, radiation dose-cancer 
associations were smaller for workers who were poten-
tially exposed to internal radiation than for those not 
exposed.48  After excluding cancers of the lung, liver, 
and bone, we observed that the magnitude of the esti-
mated excess relative rate (0.51 per Gy; 90% confidence 
interval 0.15 to 0.91) was similar for all solid cancers. 
This estimate was larger than the estimated association 
between colon dose from external ionising radiation 
exposure and mortality due to solid cancers other than 
lung, liver, and bone among workers employed at the 
Mayak Production Association in Ozyorsk, Russia (0.16 
per Gy; 0.08 to 0.24).20 Further work on internal doses is 
ongoing and could allow for increased attention to 
effects of incorporated radionuclides in future analyses.
Conclusions and implications for future research
Follow-up of large cohorts of nuclear industry workers 
has been ongoing for over 30 years; our data now yield 
sufficient statistical information to permit relatively pre-
cise estimates of cancer mortality risk in a population 
for whom average cumulative doses are about 20 mGy. 
These findings represent a substantial addition to the 
scientific basis for understanding the risks of cancer 
from protracted, low dose rate, exposure to ionising 
radiation; and underscore the value of the substantial 
efforts being made in France, the UK, and the USA to 
continue gathering data for these worker studies.
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